As CECP marks its 20th anniversary, corporate social investment is more important than ever. Looking back at the last two decades, measuring and benchmarking social investment overall has become more integrated in corporate strategies and has employed more sophisticated tools and models to evaluate progress. Since its founding, CECP has been steadfast and unparalleled in helping companies transform their social strategy and gain serious, on-going traction.
CEOs from institutional investor firms BlackRock and State Street released their annual guidance to companies on practices they “believe will drive sustainable, long-term growth, and profitability.” These letters were issued amidst widespread cynicism, both socially and economically, while anxious chatter continues about the role of business, capitalism, and strategic time horizons.
To build on the growing body of global corporate social investment research, CECP: The CEO Force for Good announced the launch of a multinational inquiry into shared themes and trends in corporate social investments around the world. CECP’s Global Exchange seeks to unite country-based, mission-driven corporate social investment organizations to advance the corporate sector as a force for good around the world. Participating organizations – each referred to as a Global Exchange Country Partner in their respective country – collective represent over 54% of the world’s population and 67% of the world’s GDP.
In second grade, when asked what he wanted to be when he grew up, Timothy Day said: “a chemist who would try to cure cancer.” He wasn’t too far off the mark. Two decades later, with biochemistry, microbiology, and neuroscience degrees in hand, Amgen Scholar alumnus Day has started his own company to to develop gene therapies for intestinal and systemic diseases.